Our sister site, Drug Delivery Business News, reports today that Insulet made its Omnipod 5 system available in Australia and has planned launches for Belgium, Canada and Switzerland in the near term. This follows the launch of Omnipod 5 in five new European countries at the start of this year.
Acton, Massachusetts–based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top prescribed AID system in the U.S. and the first tubeless, waterproof AID system with proactive glucose control.
In addition to the expanded Omnipod 5 availability, Insulet also announced its intention to offer $450 million in senior unsecured notes. Plus, there was news today that Chief Technology Officer Mark Field is departing the company.
Get the full story at our sister site, Drug Delivery Business News.
